Stockscreener 앱 받기
7.01
2.79%
0.19
시간 외 거래:
6.99
-0.02
-0.29%
Bausch Health Companies Inc 주식(BHC)의 최신 뉴스
Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake - The Motley Fool
Stock Recap: How Bausch Health Companies Inc stock benefits from global expansionJuly 2025 Snapshot & Advanced Swing Trade Entry Alerts - BỘ NỘI VỤ
Barclays Initiates Coverage of Bausch Health Companies (BHC) with Equal-Weight Recommendation - Nasdaq
BHC: Barclays Initiates Coverage with Equal-Weight Rating | BHC Stock News - GuruFocus
Bausch Health Cos Inc. $BHC is Goldentree Asset Management LP's Largest Position - MarketBeat
Bausch Health Companies Inc Announces Early Exchange Offer Results - TradingView
Bausch Health (NYSE:BHC) expects $1.6 billion of new 2032 notes in senior debt exchange - Stock Titan
Bausch Health Announces Early Exchange Offer Results for Exchange Offers - Yahoo Finance
Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - GlobeNewswire Inc.
Why Investors Shouldn't Be Surprised By Bausch Health Companies Inc.'s (NYSE:BHC) Low P/S - 富途牛牛
Bausch Health ticks higher following large director stock purchase - MSN
Is Bausch Health Companies Inc. (BVF) stock a buy before earnings resultsOptions Play & Free Community Supported Trade Ideas - Newser
Will Bausch Health Companies Inc. (BVF) stock profit from AI boomMarket Performance Summary & Accurate Intraday Trading Signals - Newser
Will Bausch Health Companies Inc. stock outperform growth indexesQuarterly Profit Report & Daily Growth Stock Tips - Newser
Can Bausch Health Companies Inc. stock sustain breakout momentumBond Market & Real-Time Stock Entry Alerts - Newser
Will Bausch Health Companies Inc. (BVF) stock sustain uptrend momentum2025 Bull vs Bear & Technical Pattern Based Buy Signals - Newser
Why Bausch Health Companies Inc. stock could rally strongly2025 Buyback Activity & Consistent Profit Focused Trading Strategies - Newser
Published on: 2025-12-04 04:20:11 - Newser
Is Bausch Health Companies Inc. stock resilient to inflation2025 Sector Review & AI Powered Market Entry Ideas - Newser
Is Bausch Health Companies Inc. stock a good hedge against inflation2025 Bull vs Bear & Smart Money Movement Alerts - Newser
John Paulson's Strategic Acquisition in Bausch Health Companies Inc. - GuruFocus
What valuation ratios show for Bausch Health Companies Inc. stockWeekly Stock Report & Technical Analysis for Trade Confirmation - Newser
Is Bausch Health Companies Inc. (BVF) stock supported by strong fundamentalsMarket Rally & Long-Term Safe Investment Ideas - Newser
Why pension funds invest in Bausch Health Companies Inc. (BVF) stock2025 Momentum Check & Weekly Breakout Watchlists - Newser
Why Bausch Health Companies Inc. stock remains top ratedEarnings Miss & AI Forecast Swing Trade Picks - Newser
Assessing Bausch Health Companies (NYSE:BHC) Valuation After a 13% YTD Decline and Recent Bounce - Sahm
BHC Stock Up as Solta Acquires Shibo's Aesthetics Distribution Business - cnhinews.com
Bausch Health Companies to Present at Cowen Annual Health Care Conference - ACCESS Newswire
Bausch Health Companies (BHC) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Bausch Health Cos (NYSE:BHC) Shares Gap UpHere's Why - MarketBeat
Transcript : Bausch Health Companies Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-02-2025 10 - marketscreener.com
Is There Now an Opportunity in Bausch Health Companies After Recent Debt Restructuring Developments? - Yahoo Finance
How higher bond yields impact Bausch Health Companies Inc. (BVF) stockJobs Report & Short-Term Swing Trade Alerts - Newser
Why analysts maintain buy rating on Bausch Health Companies Inc. (BVF) stockWeekly Volume Report & High Yield Equity Trading Tips - Newser
Why Bausch Health Companies Stock Rocketed 11% Higher Today - The Globe and Mail
Bausch Health’s Intriguing Market Moves - StocksToTrade
Why Bausch Health Companies Stock Rocketed 11% Higher Today - The Motley Fool
Bausch Health completes acquisition of Chinese aesthetics distributor By Investing.com - Investing.com Australia
Why Are Shares Of Bausch Health Up Today? - Benzinga
Stocks in play: Bausch Health Companies Inc. - The Globe and Mail
Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis - ACCESS Newswire
Director buying at Bausch Health Companies (BHC) - The Globe and Mail
0.29%
1.66%
자본화:
|
볼륨(24시간):